NewEdge Advisors’s KORU Medical Systems KRMD Stock Holding History

NewEdge Advisors’s Portfolio KRMD Stock Details KRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.86K	Buy	1,819 +1,219	+203%	+$6.04K	﹤0.01%	3459
2025 Q4	$3.49K	Hold	600	–	–	﹤0.01%	3769
2025 Q3	$2.3K	Hold	600	–	–	﹤0.01%	3749
2025 Q2	$2.15K	Hold	600	–	–	﹤0.01%	3608
2025 Q1	$1.52K	Buy	+600	New	+$2.23K	﹤0.01%	3560
2023 Q3	–	Sell	-740	Closed	-$2.55K	–	3573
2023 Q2	$2.55K	Sell	740 -1,020	-58%	-$4K	﹤0.01%	3021
2023 Q1	$7.43K	Sell	1,760 -12,168	-87%	-$47.9K	﹤0.01%	2662
2022 Q4	$43.4K	Buy	+13,928	New	+$38.4K	﹤0.01%	1778

Other funds holding KRMD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

TCM

Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simcoe Capital Spokane, Washington $109M AUM

MIM

Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return

EFMC

Empire Financial Management Company New York $442M AUM 24.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

NewEdge Advisors's KRMD Position: Q1 2026 in Review

NewEdge Advisors increased its KORU Medical Systems (KRMD) stake by 203% in Q1 2026, buying an estimated $6.04K and bringing the position to 1,819 shares worth $7.86K. The position accounts for ﹤0.01% of the portfolio, ranked #3459.

NewEdge Advisors first reported a position in KRMD in Q4 2022 and has held it in 8 quarters since. The position peaked at $43.4K in Q4 2022. 91 funds tracked by Wall St. Rank hold KRMD as of Q1 2026.

NewEdge Advisors held 1,819 shares of KORU Medical Systems worth $7.86K as of Q1 2026.
NewEdge Advisors bought 1,219 KORU Medical Systems shares in Q1 2026, an estimated $6.04K.
KORU Medical Systems made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #3459 holding.
NewEdge Advisors first reported a position in KORU Medical Systems in Q4 2022 and has held it in 8 quarters since.
NewEdge Advisors's KORU Medical Systems position peaked at $43.4K in Q4 2022.
91 funds tracked by Wall St. Rank held KORU Medical Systems as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.